Recombinantly engineered human proteins: transforming the treatment of psoriasis. [electronic resource]
Producer: 20030115Description: 105-16 p. digitalISSN:- 1521-6616
- Alefacept
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Cytokines -- antagonists & inhibitors
- Daclizumab
- Diphtheria Toxin -- therapeutic use
- Etanercept
- Humans
- Immunoglobulin G -- therapeutic use
- Immunotherapy
- Infliximab
- Interleukin-2 -- therapeutic use
- Lymphocyte Activation
- Models, Immunological
- Protein Engineering
- Psoriasis -- drug therapy
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Recombinant Proteins -- genetics
- T-Lymphocytes -- immunology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.